SD treatment followed by C18 filtration does not impact plasma hemostatic function.

Retention of plasma bioactivity following SD and C18 treatments was measured for: A. Prothrombin time (PT; sec); B. International normalized ratio (INR); and C. Activated partial thromboplastin time (APTT; sec). Control: plasma only; C18: plasma with C18 cartridge filtration; SD + C18: plasma treated with SD followed by C18 cartridge filtration. Values are means ± SEM from three independent experiments. NS = not significantly different (P > 0.05). SD treatment followed by C18 filtration does not impact plasma hemostatic function.